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 ABSTRACT 
 
  Retinoic acid (RA), a derivative of vitamin A, is well know for its ability to 
act as a transcriptional modulator, and it is critically involved in a number of 
cellular processes. The cellular retinoic acid binding proteins (CRABP-I and II) 
are small cytosolic proteins that bind to RA with a high affinity, and they are 
thought to play a role in the biological activities of RA. The expression of 
CRABP-II has been shown to selectively enhance the activity of a group of 
ligand-inducible transcription factors known as the retinoic acid receptors 
(RARs), and CRABP-II has also been shown to accumulate in the nucleus in 
response to RA treatment. CRABP-II is thought to enhance RAR activity by 
enhancing the movement of RA into the nucleus, where RAR functions as a 
transcription factor. The question addressed in this work was that of the 
mechanism by which CRABP-II accumulates in the nucleus in response to RA.  
Abolishing nuclear localization of CRABP-II, and the resulting effects on 
RAR activity were addressed. CRABP-II was tagged to a nuclear export signal 
(NES), which actively excludes a protein from the nucleus. Subsequently, the 
NES functionality was verified by fluorescence microscopy. Functional assays 
for RAR activity were performed, and it was determined that accumulation of 
CRABP-II in the nucleus was necessary for it to enhance the activity of RAR. 
  To address possible mechanisms for the nuclear localization of 
CRABP-II, analysis of its primary and tertiary structures were performed. No 
nuclear localization signals could be identified in the primary sequence of 
CRABP-II. Comparisons of the electrostatic surface potentials of  apo- and 
holo- crystal structures of CRABP-II identified a region of the protein that 
appeared to become more basic in response to RA binding. Three basic residues in the region were identified as potentially important for the change in 
the surface potential. Further analysis identified the residues as being very 
similar in orientation to a classical primary nuclear localization signal. 
 The three basic residues of CRABP-II were converted to alanines by 
mutagenesis, and the recombinant mutant was purified from E. Coli. Using the 
purified WT and mutant proteins, it was determined that mutation of the 
residues did not significantly change the proteins’ sensitivity to urea-induced 
denaturation, and that the mutations did not significantly disturb the ability of 
CRABP-II to bind RA.   
The three basic residues were then mutated in mammalian expression 
vectors, and the effects of mutating them were evaluated by microscopy. It 
was determined that the three basic residues are required for RA induced 
nuclear localization of CRABP-II. Further, it was determined that Leptomycin-B 
(LMB), an inhibitor of nuclear export, had no effect on the RA-mediated 
localization of the WT or the mutant protein, suggesting that CRABP-II nuclear 
localization is mediated by an import machinery.  
Functional assays for RAR activity were used to address the functional 
significance of the three basic residues. It was determined that the mutant 
protein was unable to enhance the activity or RAR to the same degree as WT, 
and further that the enhancement by the mutant was similar to that obtained 
using the NES-tagged WT protein. 
Further research was done to identify the proteins involved with the RA 
induced nuclear import of CRABP-II. Recombinant CRABP-II-GST was shown 
to interact with importinα, a known nuclear import-related protein, in an RA 
dependent fashion. The NLS CRABP-II mutant did not interact with importinα even in the presence of RA, further supporting the hypothesis that RA induced 
nuclear localization requires the three NLS residues.  
Overall, this work suggests a unique mechanism for nuclear import, in 
which a non-classical NLS emerges in CRABP-II in response to RA binding. 
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  viCHAPTER ONE 
INTRODUCTION 
 
1.1 RETINOIC ACID 
 
  Retinoic acid (RA) is a labile, 20 carbon fatty acid consisting of a β-
ionone ring attached to an isoprenoid chain which ends with a carboxylic acid 
moiety (figure 1.1). RA is a derivative of vitamin A, an essential nutrient that 
cannot be synthesized endogenously by mammals. Vitamin A is taken up from 
the diet, either from the pro-vitamin A carotenoids found in plants, or from 
retinyl esters found in animal products. The circulating form of vitamin A, 
retinol (ROH) can be converted into RA by a number of different tissues and 
cell types, including the uterus (Bucco et al., 1997), and the testes (Cavazzini 
et al., 2003). It is generally believed that retinoic acid is synthesized from ROH 
in cells by a two-step process in which ROH is first reversibly converted into 
retinal (RAL), and RAL is subsequently converted irreversibly into RA (Napoli, 
1999).  The conversion of ROH into RAL proceeds via a number of enzymes 
that are members of the short-chain alchohol dehydrogenase/reductase (SDR) 
family as well as the alcohol dehydrogenase (ADH) family. At least 12 SDRs, 
known as the retinol dehydrogenases (ROLDHs), have been identified (Liden 
et al., 2003). In cells, RAL is converted into RA by at least 4 enzymes in the 
aldehyde dehydrogenase (ADH) family known as the retinaldehyde 
dehydrogenases (RALDH) type 1-4 (Duester, 2001). Knock-out mice for 
RALDH2 display an embryonic lethal phenotype that is partially rescued by 
treatment with RA (Niederreither et al., 2001), suggesting that RA synthesized 
by the embryo is important for development in-utero.    
  1  2
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Figure 1.1 Retinoic acid   3
 
RA synthesis in-utero is required during embryonic development, but 
RA is also known to be toxic, as well as teratogenic, suggesting that 
maintenance of critical RA levels is important. RA is degraded in cells by 
cyp26, a member of the cytochrome P450 enzyme family (Ray et al., 1997; 
Sonneveld et al., 1998; Sonneveld and van der Saag, 1998). Cyp26 is also 
known as retinoic acid-induced P450 (P450RAI) and as its name implies, 
P450RAI expression has been shown to be greatly induced by RA in a number 
of cell types (Abu-Abed et al., 1998; de Roos et al., 1999; Marikar et al., 1998). 
At least three P450RAI retinoic acid degrading enzymes have been identified, 
known as cyp26a, b, and c. Knock-out mice lacking cyp26a1 expression die 
during mid-gestation and have a phenotype similar to that of mice treated with 
a teratogenic RA dose (Abu-Abed et al., 2001). Increasing evidence indicates 
that tight regulation of RA concentrations in cells is important, and support for 
this comes from the multiple and redundant RA synthesis and degradation 
pathways that have been identified.  
Retinoic acid is a potent regulator of transcription, and it is well known 
that RA binds to and modulates the activities of ligand-inducible transcription 
factors known as the retinoic acid receptors (RARs) (Brand et al., 1990; 
Dalman et al., 1991; Nagpal et al., 1992). RA and its modulation of RAR 
activity have been shown to play a critical role in the differentiation of cells. RA 
has been shown to be required for limb regeneration in amphibians (Maden, 
1997), and has been suggested to be able to promote the repair of damaged 
nerve tissue in mammalian whole-animal models (Zhelyaznik et al., 2003). 
Heart morphogenesis has also been shown to critically involve RA (Zhelyaznik 
et al., 2003). Chondrogenesis and skeletal progenitor cell differentiation have   4
been shown to be inhibited by RA ((Cho et al., 2003) and (Weston et al., 2002) 
respectively). RA and RAR have also been shown to inhibit the growth of a 
number of cancer cell models, including models for breast cancer (Darro et al., 
1998) and cervical cancers (Behbakht et al., 1996). RA has been used with 
some success as a treatment for certain cancers (Shen et al., 2004; Soprano 
et al., 2004), but toxicity issues involved with RA treatment have limited its 
use. 
  
1.2 NUCLEAR HORMONE RECEPTORS 
 
It is known that small lipophylic compounds can act as signaling 
molecules in a variety of critical cellular processes. Many lipids, including long-
chain fatty acids, prostaglandins, and retinoic acid, have been shown to play 
critical signaling roles in inflammation, cell growth, and differentiation. The 
wide range of processes that are effected by small lipophylic molecules come 
in part from their ability to act as signaling molecules that directly regulate 
gene expression. Many lipids and their metabolites have been shown to do so 
by acting as ligands that modulate the activity of transcription factors known as 
the nuclear hormone receptors.  
The nuclear hormone receptors consist of both the steroid and the non-
steroid hormone receptors. The steroid receptor subfamily includes the 
estrogen, androgen and glucocorticoid receptors. The non-steroid receptors, 
including the retinoic acid receptors (RAR) and peroxisome proliferator-
activated receptors (PPAR) typically bind receptor-specific lipophylic ligands 
(Laudet and Gronemeyer, 2002).    5
The nuclear hormone receptors are a structurally related class of 
proteins, containing 5-6 structural domains (A-F) of specific function (fig. 1.2). 
The amino terminal A/B domain, which is highly variable between receptors, 
possesses a ligand independent transcriptional activity. The C domain 
consists of a DNA binding domain (DBD), which contains two highly conserved 
zinc finger DNA-binding motifs that bind to receptor-specific DNA response 
elements. While the steroid receptors typically bind to DNA as homodimers, 
the non-steroid receptors bind in a heterodimer with a common partner, the 
retinoid X receptor (RXR). The D domain is a small “hinge” region that 
connects the DBD to domain E, the ligand binding domain (LBD). The more 
variable LBD possesses a ligand-inducible transcriptional activity. The LBD is 
known to be important for receptor dimerization, as well as for protein-protein 
interactions with other transcriptional effectors. The C-terminal domain F is 
variable and does not exist in a number of the nuclear hormone receptors, and 
its function is not known.   
The nuclear receptors bind to DNA as a dimer on a receptor-specific 
DNA response element. In the absence of ligands, nuclear receptors bind to 
corepressors. The corepressors down regulate the transcription of genes by 
recruiting proteins that modify chromatin, thereby inhibiting the binding of the 
general transcription machinery. When ligands bind to the receptors, a 
structural change occurs in the protein, and they release the corepressors. At 
the same time, the receptors gain an affinity for coactivator proteins, which 
induce chromatin to become accessible to the general transcription machinery, 
thereby upregulating gene expression (Bastien and Rochette-Egly, 2004; 
Dilworth and Chambon, 2001; Kinyamu and Archer, 2004; Xu et al., 1999). 
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Figure 1.2 Domain structure of the nuclear  
hormone receptors and associated functions.   7
 
Several nuclear hormone receptors are regulated by fatty acids and retinoids, 
including the peroxisome proliferator activated receptors (PPARs) and the 
retinoic acid receptors (RARs), among others.  PPARs, which are activated by 
fatty acids and some of their metabolites, (Desvergne and Wahli, 1999; 
Forman et al., 1997; Kliewer et al., 1997) are known to play roles in a number 
of critical cellular processes, and have been shown to play a role in the onset 
of diabetes and obesity (Kersten, 2002).  Drugs designed as PPAR-specific 
ligands are currently used to treat diabetes (Carey et al., 2002; Spiegelman, 
1998; Tiikkainen et al., 2004). Retinoic acid receptors (RARs) are activated by 
retinoic acid (Brand et al., 1990; Dalman et al., 1991; Nagpal et al., 1992). 
Knock-out mice for RARs suggest that their function is important for 
development (Lohnes et al., 1995; Mendelsohn et al., 1994). 
 
1.3 THE CELLULAR RETINOIC ACID BINDING PROTEINS 
 
  Retinoic acid binds to and modulates the activities of RARs, but it is 
also known to bind to the cellular retinoic acid binding proteins (CRABP-I and 
CRABP-II) with a high affinity (Dong et al., 1999).  CRABPs are members of a 
family of small structurally similar cytosolic proteins known as the intracellular 
lipid binding proteins (iLBPs).  The iLBPs are not very well conserved in their 
primary sequences, but share a very similar overall three-dimensional 
structure.  The iLBPs have a characteristic lipid binding cavity that is 
comprised of a lipid-binding pocket created by two orthogonal 5-stranded beta 
sheets, which is covered by a characteristic helix-loop-helix “lid” (figure 1.3)   8
(Gutierrez-Gonzalez et al., 2002; Kleywegt et al., 1994; Veerkamp and 
Maatman, 1995).  
The iLBPs are thought to function as shuttling proteins that bind to fatty 
acids and their metabolites and protect them in the cytosol.  Studies suggest 
that some FABPs pull their ligands from membranes by a collision-mediated 
process (Thumser and Storch, 2000).  A number of studies suggest that 
certain FABPs deliver their ligands to membranes by a similar mechanism 
(Hsu and Storch, 1996; Kim and Storch, 1992; Wootan et al., 1993) Intestinal 
fatty acid binding protein (I-FABP) is an iLBP that is highly expressed in 
enterocytes. I-FABP has been demonstrated to bind certain non-fatty acid 
lipophilic drugs, and I-FABP has been suggested to increase their cytosolic 
solubility, facilitating their transport from the intestinal lumen across the 
enterocyte (Velkov et al., 2005). 
  While many iLBPs, including I-FABP, bind to a variety of fatty acids 
and their metabolites (Hanhoff et al., 2002; Norris and Spector, 2002; 
Widstrom et al., 2001), the CRABPs bind to RA with a high selectivity, 
specificity and affinity (Dong et al., 1999).    
There are two known CRABPs in mammalian cells, CRABP-I and 
CRABP-II. They are distinct gene products but share a very high sequence 
homology (Figure 1.4).  CRABP orthologs have been found in mammals, 
birds, fishes, and amniotes.  Both CRABP transcripts are expressed in the 
embryo of mice in a specific, non-overlapping and stage dependant pattern 
(Ruberte et al., 1992), suggesting that they play distinct biological roles.  9
Figure 1.3 Crystal structures of holo- cellular retinoic acid binding  
proteins type I (top) and type II (Kleywegt et al., 1994).                                 
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  A number of reports from in vitro and in vivo studies have suggested 
that the induction of CRABP-II expression is concurrent with enzymes involved 
with the synthesis of RA (Bucco et al., 1997; Li et al., 2004). CRABP-I has 
been suggested to play a role in promoting the degradation of RA in some 
cells (Boylan and Gudas, 1991; Won et al., 2004). The unique expression 
patterns and evolutionary conservation of the CRABPs suggest that they play 
important roles in the biological activities of RA. KO mice for either CRABP-II, 
or for both CRABP-I and II, have been created (Lampron et al., 1995).   
Interestingly, the only phenotype was a relatively mild digit malformation 
that was manifest in a small percentage of offspring.CRABP-II KOs showed an 
occasional phenotype, and the CRABP-I/II double KO mice had an increased 
percentage of offspring with the same digit malformation. None of the mice 
were found to be infertile, and they developed normally. These data suggest a 
non-critical role for the CRABPs. The emergence of a phenotype may result if 
mothers were compromised in their vitamin A status, but such dietary effects 
have yet to be investigated. 
Retinoic acid is known to be a potent activator of transcription as an 
activator of RAR. It has been suggested that there is difference between 
CRABP-I and CRABP-II in their abilities to modulate RA-induced RAR 
activities (Dong et al., 1999). In a cell model system, ectopic CRABP-I 
expression has no significant effects on RAR activity in response to RA 
treatment, where as ectopic CRABP-II expression resulted in a significant 
increase in the ability of RA to stimulate RAR activity. It has also been found 
that CRABP-II is mainly cytosolic in the absence of RA, and that upon RA 
treatment CRABP-II accumulates in the nucleus (Budhu and Noy, 2002).  11
  
           1                                                   50
  CRABP-I  MPNFAGTWKM RSSENFDELL KALGVNAMLR KVAVAAASKP HVEIRQDGDQ 
 CRABP-II  MPNFSGNWKI IRSENFEELL KVLGVNVMLR KIAVAAASKP AVEIKQEGDT 
  
           51                                                 100
  CRABP-I  FYIKTSTTVR TTEINFKVGE GFEEETVDGR KCRSLATWEN ENKIHCTQTL 
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           101                                   138 
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   Figure 1.4 Alignment of human CRABP-I and CRABP-II  
amino acid sequences. Sequence homology is in bold print.  
Alignment was done using Multalin (Corpet, 1988) and  
accession #’s NM_004378 (CRABP-I) and # NM_001878  
(CRABP-II).   12
The CRABPs, like other iLBPs, are believed to transport their labile ligands 
through the cytoplasm of cell. CRABP-II is thought to enhance RAR 
transcriptional activities by enhancing the movement of RA into the nucleus, 
where RAR functions as a transcription factor (Bastie et al., 2001; Budhu et 
al., 2001; Budhu and Noy, 2002). 
 
1.4 OVERALL RESEARCH GOAL 
 
  Previous work has shown that CRABP-I and CRABP-II differ in their 
ability to modulate the transcriptional activities of RAR. Expression of CRABP-
II appears to dramatically enhance RA-induced RAR transcriptional activity in 
cells while CRABP-I does not. CRABP-II has also been suggested to 
“channel” retinoic acid to RAR through a transient protein-protein interaction 
in-vitro, while CRABP-I does not. CRABP-I and CRABP-II are both cytosolic in 
the absence of RA, and while CRABP-II is localized to the nucleus in response 
to RA binding, CRABP-I remains in the cytoplasm.  
  The work presented in this thesis was undertaken in order to further 
investigate the biological role of CRABP-II. The goal of these studies was to 
investigate the mechanisms for RA-induced changes in the subcellular 
localization of CRABP-II. 
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2.1 SUMMARY 
 
  Primary sequences of proteins often contain motifs that serve as 
‘signatures’ for subcellular targeting, such as a nuclear localization signal 
(NLS).  However, many nuclear proteins do not harbor a recognizable NLS 
and the pathways that mediate their nuclear translocation are unknown.  This 
work focuses on CRABP-II, a cytosolic protein that moves to the nucleus upon 
binding of retinoic acid.  While CRABP-II does not contain an NLS in its 
primary sequence, such a motif could be recognized in the protein’s tertiary 
structure.  We map the retinoic acid-induced structural rearrangements that 
result in the presence of this NLS in holo- but not apo-CRABP-II.  The signal, 
whose three-dimensional configuration aligns strikingly well with a ‘classical’ 
NLS, mediates ligand-induced association of CRABP-II with importinα and is 
critical for nuclear localization of the protein.  The ligand-controlled NLS 
“switch” of CRABP-II may represent a general mechanism for post-
translational regulation of the subcellular distribution of a protein. 
 
2.2 INTRODUCTION 
  
  Small lipophilic compounds often play important roles in regulating 
biological functions.  Many such molecules, e.g. retinoic acid, long chain fatty 
acids and eicosanoids, function by activating ligand-inducible transcription 
factors that are members of the super-family of nuclear hormone receptors 
(Laudet and Gronemeyer, 2002).  Hence, retinoic acid activates retinoic acid 
receptors (RAR) (Dalman et al., 1991; Nagpal et al., 1992) while fatty acids 
and some of their metabolites activate peroxisome proliferator-activated   24
receptors (PPAR) (Desvergne and Wahli, 1999; Forman et al., 1997; Kliewer 
et al., 1997).  Lipophilic ligands thus regulate the expression of genes that 
control various aspects of cellular metabolism, proliferation, and differentiation.  
Type II nuclear receptors, including RAR and PPAR, bind to DNA response 
elements as heterodimers with a common partner, the retinoid X receptor, and 
regulate transcription in response to their cognate ligands (Aranda and 
Pascual, 2001; Chambon, 1996; Laudet and Gronemeyer, 2002).  While the 
mechanisms by which ligands modulate the activities of nuclear receptors 
have become increasingly clear (Bastien and Rochette-Egly, 2004; Dilworth 
and Chambon, 2001; Xu et al., 1999), an important question that remains 
open is how these ligands, which are poorly soluble and often labile in 
aqueous environments, traverse the cytoplasm, enter the nucleus, and reach 
their cognate receptors. 
 In addition to nuclear receptors, many lipophilic compounds bind in 
cells to intracellular lipid binding proteins (iLBPs), a family of small (~15 kDa) 
proteins that share a remarkably similar β-clam structure comprised of two 5-
stranded orthogonal β-sheets that form a ligand binding pocket, and a single 
helix-loop-helix “lid” that appears to limit ligand access (Gutierrez-Gonzalez et 
al., 2002; Kleywegt et al., 1994; Veerkamp and Maatman, 1995).  Although 
similar in structure, iLBPs diverge in their primary sequences and they bind 
lipophilic molecules with distinct selectivities.  Cellular retinol binding proteins 
(CRBP-I and II) bind retinol and retinaldehyde with high specificity (Levin et al., 
1988; Noy and Blaner, 1991), and cellular retinoic acid binding proteins 
(CRABP-I and II) associate with retinoic acid with subnanomolar affinities 
(Dong et al., 1999).  In contrast, other iLBPs, known as fatty acid binding 
proteins (FABPs), display broad selectivities and bind a variety of ligands with   25
similar affinities (Hanhoff et al., 2002; Norris and Spector, 2002; Widstrom et 
al., 2001). 
The evolutionary conservation of iLBPs suggests that they play 
important roles in the biological activities of their ligands but these functions 
remain incompletely understood.  These proteins are thought to act as carriers 
for their ligands, serving to solubilize and protect them in the aqueous 
environment of the cytosol.  In addition to this general role, it has been 
suggested that particular iLBPs may have specific functions.  It was proposed 
that some iLBPs facilitate the movement of fatty acids into membranes (Kim 
and Storch, 1992; Wootan et al., 1993), that K-FABP interacts with the calcium 
binding protein psoriasin (Hagens et al., 1999a; Hagens et al., 1999b), and 
that A-FABP and K-FABP directly associate with hormone sensitive lipase 
(Jenkins-Kruchten et al., 2003; Shen et al., 2001).  The structural basis for and 
the functional consequence of these interactions remain to be clarified.  
Our recent studies demonstrated that three iLBPs play selective roles in 
enhancing the transcriptional activities of nuclear receptors with which they 
share a common ligand. Specifically, we showed that CRABP-II, K-FABP and 
A-FABP enhance the ligand-induced transcriptional activities of RARα, 
PPARβ/δ and PPARγ, respectively.  The data established that these iLBPs 
exert their effects by directly interacting with the respective receptors, and that 
the resulting complexes mediate “channeling” of ligands to the receptors, 
thereby facilitating their ligation and enhancing their transcriptional activities 
(Budhu and Noy, 2002; Dong et al., 1999; Tan et al., 2002).  
Direct interactions between iLBPs and nuclear receptors require that 
the two types of proteins colocalize in the same subcellular compartment at 
least under some conditions.  This is a non-trivial issue because nuclear   26
receptors function in the nucleus while iLBPs are usually believed to be 
cytosolic.  Studies of the subcellular localization of CRABP-II, K-FABP and A-
FABP revealed that these proteins are indeed cytosolic in the absence of 
ligands, but that they translocate to the nucleus upon treatment of cells with 
appropriate ligands (Budhu and Noy, 2002; Tan et al., 2002).  These 
observations raise the question of the structural basis for the ligand-induced 
nuclear localization of these iLBPs. 
The best characterized nuclear localization signal (NLS) of proteins is 
exemplified by the ‘classical’ NLS of the SV40-T antigen which is identifiable in 
the primary sequence of a protein as a series of basic residues in the form 
K(K/R)X(K/R) (Chook and Blobel, 2001; Dingwall and Laskey, 1991; Hodel et 
al., 2001; Kalderon et al., 1984; Robbins et al., 1991).  Such an NLS is often 
recognized by adapter proteins known as α-importins which, in turn, associate 
with one of the various forms of importinβ to mediate nuclear localization 
(Chook and Blobel, 2001).  It has also been reported that importinβ can 
interact directly with some cargoes.  While nuclear targeting sequences 
recognized by importinβ are less well understood and may vary, it has been 
shown that, in some cases, such sequences are reminiscent of ‘classical’ NLS 
in that they are comprised of regions rich in basic residues (Palmeri and 
Malim, 1999; Truant and Cullen, 1999).   
Here, we undertook to identify the region that mediates the ligand-
induced nuclear localization of CRABP-II, a protein which, like other iLBPs, 
does not contain any recognizable NLS in its primary sequence.  Considering 
that CRABP-II moves to the nucleus only when ligated, we reasoned that 
ligand-binding must induce a conformational change that enables nuclear 
targeting.  Comparison of the electrostatic surface potentials of apo- and holo-  27
CRABP-II revealed a positively-charged surface patch which is present in the 
holo- but not the apo-protein.  We show that this patch is comprised of three 
basic residues whose configuration in the tertiary structure of holo-CRABP-II is 
similar to the 3-dimensional configuration of a ‘classical’ NLS.  We show 
further that this motif is essential for association of CRABP-II with 
importin￿hSRP1 as well as for the protein’s ligand-induced nuclear 
localization.  The data thus demonstrate the presence of a ligand-controlled 
NLS “switch” that is manifested in the tertiary, but not the primary, structure of 
CRABP-II. 
 
2.3 RESULTS 
 
2.3.1 CRABP-II accumulates in the nucleus in response to RA. 
 
An important step in the process that enables CRABP-II to enhance the 
transcriptional activity of RAR (Budhu et al., 2001; Budhu and Noy, 2002; 
Dong et al., 1999) is a ligand-induced nuclear translocation of the binding 
protein.  Such a response was previously shown to take place in COS-7 cells 
(Budhu and Noy, 2002).  To examine whether RA-induced nuclear targeting is 
a general feature of CRABP-II, we used MCF-7 mammary carcinoma cells, 
which endogenously express this protein at a level of over an order of 
magnitude higher than COS-7 cells (data not shown).  MCF-7 cells were 
maintained in delipidated serum to deplete vitamin A and RA pools, treated 
with RA for 30 min., fixed, immunostained with CRABP-II antibodies and 
imaged by confocal fluorescence microscopy (Fig. 2.1).     28
Similarly to its localization in COS-7 cells, CRABP-II in untreated MCF-7 cells 
was found to be extra-nuclear (Fig. 2.1A-2.1C).  In contrast with the apparent 
uniform distribution of unligated CRABP-II in cytosol of COS-7 cells (Budhu 
and Noy, 2002), CRABP-II in untreated MCF-7 cells accumulated in the 
perinuclear region where it displayed a punctate pattern, suggesting that it is 
associated with specific subcellular organelle(s).  The differences in the 
appearance of apo-CRABP-II in the two cell types could relate to variations in 
its expression levels or to differential expression of binding partners.  
Nevertheless, similarly to its response in COS-7 cells, CRABP-II in RA-treated 
MCF-7 cells was found almost exclusively in the nucleus (Fig. 2.1D-2.1F.).  
Hence, ligand-induced nuclear localization is a general feature of CRABP-II. 
  To further examine the subcellular localization of CRABP-II and to 
enable subsequent mutagenesis analyses using live cells, a construct of the 
protein fused to green fluorescent protein (GFP) was used.  COS-7 cells were 
transfected with an expression vector encoding GFP-tagged CRABP-II and 
cells were imaged prior to or following a 30 min. treatment with RA.  As a 
control, cells were transfected with a plasmid expressing GFP alone.  GFP 
was distributed across the cells (Fig. 2.2A), most likely reflecting that its high 
expression level resulted in leakage into the nucleus even in the absence of a 
specific NLS.  The distribution of GFP was not affected by RA treatment (Fig. 
2.2B).  Similarly, the high level of expression of GFP-tagged CRABP-II in 
untreated cells resulted in a distribution in the cytosol as well as the nucleus 
and in loss of the punctate perinuclear pattern observed for endogenous 
CRABP-II (compare Fig. 2.2C with Fig. 2.1A).    29
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.  CRABP-II localizes to the nucleus in response to RA.  MCF-7 cells 
were treated with ethanol (A-C) or 100 nM RA (D-F) for 30 min.  (A,D) 
Immunostaining with CRABP-II antibodies; (B,E) Imaging of nuclei using the 
nucleic acid stain ToPro3;  (C,F) Overlay of images of CRABP-II and nuclei.  
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Nevertheless, like the behavior of endogenously-expressed CRABP-II, 
addition of RA led to accumulation of GFP-CRABP-II in the nucleus, a process 
that appeared to be complete within 30 min. (Fig. 2.2D).  Hence, while over-
expression GFP-CRABP-II somewhat masked the proper distribution of the 
unligated protein, the construct properly underwent a ligand-induced nuclear 
translocation. 
 
2.3.2 RA induces nuclear import of CRABP-II.   
 
Accumulation of CRABP-II in the nucleus in response to RA may reflect 
ligand-induced nuclear import.  Alternatively, RA may inhibit the nuclear export 
of the protein.  To distinguish between these possibilities, the localization of 
CRABP-II was examined in the presence of leptomycin B (LMB), a compound 
that inhibits nuclear export mediated by nuclear export signals (NES).  To 
verify the efficacy of LMB treatment, we generated a CRABP-II construct 
comprised of CRABP-II fused to an NES of the sequence 
MDLCQAFSDVILAEF, which mediates active export from the nucleus by the 
CRM-1 export machinery (Moroianu, 1999; Sweitzer et al., 2000).  NES-GFP-
CRABP-II was excluded from the nucleus both in the absence and in the 
presence of RA (Fig. 2.2E and 2.2F).  In contrast, in cells treated with LMB, 
CRABP-II harboring the NES was distributed across the cells in the absence 
of RA, and translocated into nucleus in the presence of RA (Fig. 2.2G and 
2.2H).   Similarly, RA treatment resulted in nuclear accumulation of WT GFP-
CRABP-II regardless of the presence of LMB (Fig. 2.2I and 2.2J).  Hence, RA 
triggers nuclear accumulation of CRABP-II by inducing its nuclear import and 
not by inhibiting nuclear export.          
D  F  E   31
 
    -                    +RA 
A  B 
GFP 
GFP-CRABP-II 
GFP-CRABP-II-NES 
GFP-CRABP-II-NES + LMB 
D  C 
G  H 
I  J 
E F
 
 
 
 
 
 
 
 
 
 
 
 
 
GFP-CRABP-II + LMB   
 
 
Figure 2.2.  RA induces nuclear import of GFP-CRABP-II.  COS-7 cells were 
transfected with expression vectors harboring the denoted CRABP-II 
constructs.  Images of GFP-tagged proteins were acquired from live cells 
before (A,C,E,G,I) or after (B,D,F,H,J) a 30 min. treatment with RA (1 μM).  
Treatment with leptomycin B (LMB, 5 ng/ml) was carried out for 5 hours prior 
to and throughout imaging.   32
2.3.3 Identification of a putative NLS in holo-CRABP-II. 
 
We then set out to delineate the structural basis for RA-induced nuclear 
targeting of CRABP-II.  As the primary sequence of CRABP-II does not harbor 
any recognizable NLS sequence, we considered that the observations that 
nuclear targeting of the protein is controlled by RA imply that ligand-binding 
must induce a conformational change that results in recognition by nuclear 
import protein(s).  Examination of the X-ray crystal structures of apo- and holo-
CRABP-II (Chen et al., 1998; Kleywegt et al., 1994) showed however that the 
two structures are virtually super-imposable when viewed as ribbon models 
(Fig. 2.3A).  We then compared the combined electrostatic surface potentials 
and molecular surfaces of the two forms of the protein.  The comparison (Fig. 
2.3B) revealed a surface patch in the helix-loop-helix region of CRABP-II 
whose electrostatic potential is neutral in apo-CRABP-II and becomes basic in 
the holo-protein.  This shift could be mapped to the protein’s second helix, a 
region that was previously noted to undergo a small structural rearrangement 
upon ligand binding (Chen et al., 1998; Wang and Yan, 1999).  Specifically, 
the N-terminal of helix 2, which is loose in apo-CRABP-II, tightens to become 
part of the helix in the holo-protein (Fig. 2.3C).  Consequently, two basic 
residues, R29 and K30, which are directed inward in apo-CRABP-II, rotate 
towards the surface in the holo-form (Fig. 2.3D).  An additional shift was 
observed in the position of K20 in the first helix (Fig. 2.3D).   
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Figure 2.3.   Structural features of CRABP-II and alignment of holo-CRABP-II-
K20/R29/ K30 with the NLS of the SV40-T antigen..  (A) Superposition of the 
of apo- (blue) (Chen et al., 1998) and holo-CRABP-II (green) (Kleywegt et al., 
1994).  Bound RA is shown in gray.  (B) Computed electrostatic surface 
potentials of apo- and holo-CRABP-II (see Experimental Procedures).  Basic, 
acidic, and neutral charges are denoted by blue, red, and white, respectively.  
A positively charged patch (arrow) is manifested in holo-CRABP-II.  (C) 
Structures of helix 2 of apo- and holo-CRABP-II showing the region that 
tightens in response to RA binding (arrows).  (D) Structures of the helix-loop-
helix regions of apo- and holo-CRABP-II showing that three basic residues,  
K20, R29 and K30, change positions upon ligation.  (E) Structures of helix 1 
showing increased distance between E17 and K20 in the holo-protein.  (F) 
Structure of the SV40 NLS peptide bound to karyopherinα (Conti et al., 1998).  
K128, K129 and K131 (blue) comprise the consensus NLS of SV40.  (G) 
Superposition of residues K20, R29 and K30 of holo-CRABP-II (green) with 
K128, K129 and K131 of the SV40 NLS peptide (blue). 
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In apo-CRABP-II, K20 is placed in close proximity to E17, suggesting 
electrostatic interactions between the two residues (Fig. 2.3E).  In the holo-
protein, a twist in E17 distances it from K20 likely allowing for the observed re-
positioning of the latter.  Overall, the model shows that all three basic residues 
of the helix-loop-helix region, K20, R29, and K30, contribute to the basic 
surface patch that emerges upon protein ligation. 
  As known NLS sequences are comprised of basic residues, it is 
possible that the positively charged surface patch of holo-CRABP-II represents 
a novel NLS.  We thus compared the structure of the helix-loop-helix region of 
holo-CRABP-II to that of the ‘classical’ NLS of the SV40-T antigen which has 
been solved in complex with karyopherinα, the yeast orthologue of mammalian 
importinα (Conti et al., 1998).  In the crystal, an SV40 NLS peptide is bound to 
each of the two NLS binding sites of karyopherinα.  One of these sites, known 
as the “major site”, is thought to be more important in NLS recognition (Chook 
and Blobel, 2001; Conti et al., 1998; Hodel et al., 2001) and was thus used in 
the analysis (Fig. 2.3F).  Comparison of the helix-loop-helix region of holo-
CRABP-II with the karyopherinα -bound SV40 NLS peptide (Figure 2.3G) 
shows a close alignment of CRABP-II-K20, R29, and K30 with the basic 
residues of the SV40 NLS-K131, K129, and K128, respectively.   
 
2.3.4 RA induces association of CRABP-II with importin α and mutations of 
K20, R29, and K30A hinder the interactions. 
 
The similarity between the 3-dimensional configuration of the basic 
helix-loop-helix residues of holo-CRABP-II and a ‘classical’ NLS suggests that 
these residues may enable an importin-mediated nuclear transport of the   36
protein.  We thus studied the ability of CRABP-II to bind to an importin and the 
role of K20, R29, and K30 in such an interaction.  A CRABP-II mutant in which 
these residues were replaced by alanines was generated.  To examine 
whether the mutations disrupt the overall folding of the protein, WT and mutant 
CRABP-II were expressed in E. coli, purified (Fig. 2.4A), and subjected to 
urea-induced denaturation.  Denaturation was followed by monitoring the 
protein’s fluorescence emission spectrum whose peak shifted from 343 nm in 
the absence of urea to 357 nm upon complete unfolding (Fig. 2.4B, inset).  
The shifts in the emission spectra of WT-CRABP-II and its K20A/R29A/K30A 
mutant at increasing urea concentrations were recorded in the form of the ratio 
of fluorescence intensities at peak emission of the folded and unfolded 
proteins (Fig. 2.4B).  The data show that the urea sensitivities of WT and 
mutant CRABP-II are all but identical, indicating that the global folding 
characteristics of the mutant are intact. To further verify the viability of the 
mutant, the equilibrium dissociation constant (Kd) for its association with RA 
was measured.  Measurements were carried out by fluorescence titrations, a 
frequently used method based on the observations that, due to the extensive 
overlap of fluorescence emission spectra of proteins and the absorption 
spectrum of retinoids. To further verify the viability of the mutant, the 
equilibrium dissociation constant (Kd) for its association with RA was 
measured.  Measurements were carried out by fluorescence titrations, a 
frequently used method based on the intrinsic fluorescence of retinoid-binding 
proteins is quenched upon ligand-binding (Cogan et al., 1976; Fiorella and 
Napoli, 1991; Kersten et al., 1995; Noy et al., 1992).   37
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4.  RA induces association of CRABP-II with importinα and mutations 
of K20, R29, and K30 hinder the interactions.  (A) SDS-PAGE of bacterially 
expressed WT-CRABP-II and its mutant (KRK/AAA).  (B) Urea-induced 
unfolding of CRABP-II (squares) and mutant (circles).  Inset: Fluorescence 
emission spectra of WT-CRABP-II (λex = 283 nm) in the absence (solid line) or 
presence (dotted line) of 9 M urea.  Urea-induced shift in emission spectra is 
presented as the ratio of fluorescence intensities at 343 nm and 357 nm.  (C) 
Representative fluorescence titrations of WT- and mutant CRABP-II.  Data 
were fitted to an equation derived from simple binding theory (solid line 
through data points).  (D) GST pull-down experiments using 
35S-labeled 
importin￿hSRP1 and GST, or GST-tagged CRABP-II, or its mutant 
(KRK/AAA), in the presence or absence of RA (1.5 ￿M).  
35S- importin￿ and 
bait proteins were visualized by autoradiography and by Coomassie-blue 
staining, respectively.  The experiment was carried out three times with similar 
results.  (E) Quantitation of bands in panel 4D.  Intensities were measured 
using Alpha Innotech AlphaEase ver. 5.5 software for image capture and 
densitometry, and normalized to intensity observed with unliganded WT-
CRABP-II.    
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It should be noted that, because of sensitivity limitations, fluorescence 
titrations are usually carried out using protein concentrations that are 
significantly higher than the Kd (Dong et al., 1999).  Hence, derived values 
should be considered to comprise upper limits for the actual values (see (Noy, 
1998)).  Analyses of titration curves of WT and mutant CRABP-II (Fig. 2.4C) 
yielded Kd values of 11.4±8.6 nM and 21.5±10.5 nM, respectively, 
demonstrating that the mutations did not hamper high affinity RA-binding by 
the protein.  
The ability of CRABP-II to associate with importin α (hSRP1 alpha, (Weis et 
al., 1995)) was then examined.  
35S-labeled importin α was generated by 
coupled in vitro transcription/translation, and GST-tagged CRABPs were 
purified from over-expressing E. coli.  Association of importin α with CRABP-II 
and its K20A/R29A/K30A mutant was studied by co-precipitation assays.  
GST-tagged CRABPs and GST alone, serving as a control, were immobilized 
on glutathione agarose beads, and incubated with 
35S-importin α in the 
presence or absence of RA.  Beads were centrifuged and washed, and 
pelleted proteins resolved by SDS-PAGE.  Importin α that co-precipitated with 
immobilized proteins was visualized by autoradiography (Fig. 2.4D).  A weak 
and seemingly non-specific association between CRABP-II and importinα was 
observed in the absence of ligand, but the interaction was considerably 
stabilized in the presence of RA.  In contrast, association of importinα with the 
CRABP-II homolog CRABP-I remained at baseline both in the absence and in 
the presence of RA (data not shown).  Mutation of the residues proposed to 
comprise the NLS of CRABP-II markedly hindered the ligand-stimulated 
interactions of importinα with the protein.  We note that only a small fraction of 
the importinα input co-precipitated with CRABP-II, suggesting that the   40
interaction is relatively weak and thus that another importin subtype may be 
involved in mediating the nuclear import of the protein in vivo.  Nevertheless, 
the observations that CRABP-II binds to an importinα that the interaction is 
ligand-dependent, and that mutation of K20, R29, and K30 hinders the 
association strongly support the identification of these residues as the NLS of 
CRABP-II.  
 
2.3.5 Residues K20, R29, and K30 are critical for ligand-induced nuclear 
localization of CRABP-II.  
 
The consequences of mutating the putative NLS for the ability of CRABP-II to 
undergo a ligand-induced nuclear localization were then investigated.  COS-7 
cells were transfected with expression vectors encoding GFP-tagged WT- or 
mutant-CRABP-II and imaged prior to or following a 30 min. treatment with 
RA.  The images (Fig. 2.5) clearly show that, in contrast with the WT protein, 
the sub-cellular distribution of GFP-CRABP-II-K20A/R29A/K30A did not shift 
upon addition of RA.  Hence, residues K20, R29 and K30 are essential for RA-
induced nuclear import of CRABP-II. 
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Figure 2.5.  Mutation of the putative NLS abolishes ligand-induced 
nuclear localization of CRABP-II.  COS-7 cells were transfected with GFP-WT-
CRABP-II or its K20A/R29A/K30A mutant (KRK/AAA).  Images of GFP-tagged 
proteins (green) and of the nuclear marker Red1-nuc (blue) were acquired 
from live cells before or after a 30 min. treatment with RA (1 μM).   42
 
 
2.3.6 NLS-mediated nuclear localization is critical for enabling CRABP-II to 
enhance the transcriptional activity of RAR. 
 
To examine whether nuclear localization of CRABP-II is required for the ability 
of the protein to enhance the transcriptional activity of RAR, we used CRABP-
II that harbors an NES and is excluded from the nucleus both in the absence 
and in the presence of RA (Fig. 2.2).  The effects of nuclear exclusion on the 
transcriptional activity of CRABP-II were studies by transactivation assays.  
COS-7 cells were transfected with an expression vector harboring WT or NES-
CRABP-II together with a luciferase reporter vector driven by an RAR 
response element.  Cells were treated with RA, and luciferase activity was 
measured (Fig. 2.6).  While expression of WT-CRABP-II significantly 
enhanced the RA-induced, RAR-mediated, activation of the reporter gene, 
fusing an NES to CRABP-II completely abolished the effect of the binding 
protein. Hence, movement into the nucleus is essential for the ability of 
CRABP-II to augment the transcriptional activity of RAR.  These observations 
provide an additional approach for testing whether residues K20, R29, and 
K30 comprise the NLS of CRABP-II.  If these residues indeed mediate the 
nuclear localization of the protein, their mutation will inhibit the activation of 
RAR by CRABP-II.  To examine this prediction, transactivation assays were 
carried out in COS-7 cells transfected with CRABP-II-K20A/R29A/K30.    43
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Figure 2.6.  Nuclear localization is required for CRABP-II-mediated 
enhancement of the transcriptional activity of RAR. COS-7 cells were 
transfected with a luciferase reporter driven by an RAR response element, a 
pCH110 vector (internal standard) and either an empty vector (pSG5), or 
expression vectors for the denoted CRABP-II constructs.  Cells were treated 
with RA (250 nM) or vehicle overnight prior to measurements of luciferase 
activity.  Luciferase activity was normalized to β-gal activity and fold activation 
is presented.  Data are means ± standard deviation (n = 9).   44
The data (Fig. 2.6) show that, mutation of the putative NLS dramatically 
diminished the ability of CRABP-II to augment transcriptional activation by 
RAR although it did not abolish it completely.  The residual activity may be 
attributed to leakage of the over-expressed mutant into the nucleus even in the 
absence of a specific NLS (Fig. 2.5). 
 
2.4 DISCUSSION 
 
Many proteins that do not contain a recognizable NLS in their primary 
sequence are nevertheless found in the nucleus, raising the question of how 
their nuclear localization is accomplished (Chkheidze and Liebhaber, 2003; 
Wang et al., 1997; Wolff et al., 2002; Yamaki et al., 2004).  The present work 
was undertaken in order to identify the region in CRABP-II, a member of the 
iLBP protein family, that mediates its nuclear localization.  The question is of 
particular interest not only because CRABP-II does not harbor a familiar NLS, 
but also because its NLS functions as a ligand-activated switch triggered by 
RA (Fig. 2.1).  Analyses of  the 3-dimensional structures of apo- and holo-
CRABP-II revealed a surface patch that is neutral in the absence of ligand and 
becomes positively charged in the holo-protein.  This patch was mapped to 
three basic amino acid residues, K20, R29, and K30, that shift their orientation 
upon ligation to place their side chains in a close alignment with the ‘classical’ 
NLS of the SV40-T antigen when bound to karyopherinα (Fig. 2.3).  Hence, 
subtle, ligand-induced, shifts in the tertiary structure of CRABP-II resulted in 
the appearance of a recognizable NLS.  Subsequent analyses demonstrated 
that RA induces the association of CRABP-II with importinα, and that mutation 
of the putative NLS markedly diminishes the ligand-stimulated interaction (Fig.   45
2.4D and 2.4E).  Correspondingly, we found that K20, R29, and K30 are 
critical for mediating the nuclear localization of CRABP-II (Fig. 2.5) and for 
enabling the protein to exert its nuclear activity (Fig. 2.6).  Taken together, the 
data substantiate that K20, R29, and K30 of CRABP-II function as the 
protein’s NLS.  The identification of this signal suggests that proteins that do 
not possess a nuclear targeting sequence in their primary structure may 
localize to the nucleus by using an NLS which is manifested in their folded 
state.  It is interesting to note that nuclear import of STAT1 and STAT2 was 
reported to be mediated by a related phenomenon.  Specifically, it was shown 
that interferon-stimulated phosphorylation of these proteins induces their 
heterodimerization and creates a 3-dimentional arrangement of a Lys/Arg-rich 
region which forms a functional NLS (Fagerlund et al., 2002; Melen et al., 
2001).  Taken together with the present data, these observations suggest that 
“structural NLSs” may function to enable the regulation of the subcellular 
distribution of proteins by post-translational mechanisms.   
Proteins that harbor classical NLSs are often targeted to the nucleus 
through association with α-importins (Chook and Blobel, 2001).  Despite the 
tight sequence conservation of such NLS, binding affinities of importins 
towards their multiple cargoes differ widely (Freedman and Yamamoto, 2004; 
Kohler et al., 1999; Miyamoto et al., 1997).  Hence, although the presence of 
an NLS is critical for nuclear localization, association with the appropriate 
importin appears to be regulated by other features, as for example, by the 
exact nature of the regions flanking the NLS.  The present findings 
demonstrate that CRABP-II possesses a version of a classical NLS which 
enables its importin-mediated nuclear transport.  The identity of the importin 
isotype that mediates the process in vivo, and the additional structural   46
characteristics that contribute to importin-binding by CRABP-II remain to be 
elucidated. 
In the nucleus, CRABP-II directly interacts with the nuclear receptor 
RAR to form a complex that mediates RA-channeling to the receptor.  
Consequently, CRABP-II facilitates the ligation of RAR, augments its 
transcriptional activity, and dramatically enhances the sensitivity of cells to the 
biological activities of RA (Budhu et al., 2001; Budhu and Noy, 2002; Dong et 
al., 1999; Manor et al., 2003).  Similarly to CRABP-II, two other iLBPs, A-
FABP and K-FABP, were shown to move to the nucleus in response to 
cognate ligands and to enhance the transcriptional activities of particular 
nuclear receptors (Tan et al., 2002).  Also similarly to CRABP-II, neither of 
these iLBPs harbor a recognizable NLS in their primary sequence.  Alignment 
of the primary sequences of several iLBPs (Fig. 2.7) shows that the three 
basic residues that comprise the NLS of CRABP-II are present in both A-FABP 
and K-FABP, suggesting that they also may possess a CRABP-II-like “3-
dimensional NLS”.   
The alignment of the primary sequences of iLBPs (Fig. 2.7) further shows that 
residues homologous to the CRABP-II NLS are present in proteins that are 
believed to function outside the nucleus, i.e. CRABP-I, CRBP-I, and CRBP-II.  
These observations suggest that the configuration of these residues is distinct 
in different iLBPs. 
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FABP1(lFABP) ....MSFSGK YQLQSQENFE AFMKAIGLPE ELIQ..KGKD IKGVSEIVQN  
  FABP2(iFABP) ....MAFDST WKVDRSENYD KFMEKMGVNI VKRK..LAAH DNLKLTITQE 
FABP3(hFABP) ..MVDAFLGT WKLVDSKNFD DYMKSLGVGF ATRQ..VASM TKPTTIIEKN 
  FABP4(aFABP) ..MCDAFVGT WKLVSSENFD DYMKEVGVGF ATRK..VAGM AKPNMIISVN 
FABP5(eFABP) MATVQQLEGR WRLVDSKGFD EYMKELGVGI ALRK..MGAM AKPDCIITCD  
  CRABP-I      ...MPNFAGT WKMRSSENFD ELLKALGVNA MLRKVAVAAA SKPHVEIRQD 
CRABP-II     ...MPNFSGN WKIIRSENFE ELLKVLGVNV MLRKIAVAAA SKPAVEIKQE 
CRBP-I       ..MPVDFTGY WKMLVNENFE EYLRALDVNV ALRK..IANL LKPDKEIVQD   
CRBP-II      ..MTRDQNGT WEMESNENFE GYMKALDIDF ATRK..IAVR LTQTKVIDQD  
 
 
Figure 2.7.  Alignment of iLBPs with the NLS-containing region of CRABP-II.  
Some iLBPs contain residues that correspond in charge to the CRABP-II-NLS 
(underlined), while others do not (bold).  Alignment was accomplished using 
accession #s: NP_001869 (hCRABP-II), P15090 (hA-FABP), NP_001435 (hK-
FABP), NP_004369 (hCRABP-I), NP_002890 (hCRBP-I), NP_004155 
(hCRBP-II), NP_001434 (hL-FABP), P12104 (hI-FABP), and P05413 (hH-
FABP).   
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Indeed, it was reported that ligand-binding by various iLBPs alters the 
structures of their helix-loop-helix regions, (Hodsdon and Cistola, 1997; Wang 
and Yan, 1999), but that the resulting configuration and structural dynamics 
are distinct.  For example, in CRBP-I, the region appears to be loose in the 
apo-protein and to become more rigid upon binding of retinol.  In contrast, the 
corresponding region in CRBP-II is rigid both in the apo- and in the holo-forms 
(Lu et al., 2003).  Interestingly, while CRABP-I contains basic residues in 
positions corresponding to the NLS of CRABP-II, it does not target the nucleus 
in response to RA (Budhu and Noy, 2002).  Preliminary comparison of the 
structures of CRABP-I and CRABP-II suggests that two of the CRABP-II-NLS 
residues, K20 and K30, are aligned differently in CRABP-I.  Other features of 
the proteins, such as their dynamics or their overall patterns of hydrophobicity 
and electrostatic potential, may also contribute to the differential subcellular 
location of the two CRABPs. 
The diversity and evolutionary conservation of members of the iLBP 
family indicate that they play important roles in the biology of their ligands, but, 
to-date, neither sequence analyses nor structural data have provided clear 
insights into their functions.  Here we show that the helix-loop-helix of iLBPs 
can function as a switch that is controlled by ligand-induced subtle but 
concerted rearrangements of multiple protein regions.  In the case of CRABP-
II, and perhaps K-FABP and A-FABP, the region functions as an NLS.  
Considering the structural similarities of iLBPs, it is likely that the ability of the 
region to relay ligand-binding information is common throughout the family.  
This switch may serve to direct different iLBPs to different cellular targets, 
enabling them to mediate divergent functions in response to their cognate 
ligands.       49
 
2.5 EXPERIMENTAL PROCEEDURES 
 
2.5.1 Reagents 
  Antibodies for CRABP-II were provided by Pierre Chambon (IGBMC, 
Illkirch, France).  RA was purchased from Sigma Chemical Co.  
 
2.5.2 Modeling 
Modeling was carried out using coordinates from 1XCA (Chen et al., 
1998), 1CBS and 1CBR (Kleywegt et al., 1994), and 1BK6 (Conti et al., 1998) 
deposited in the Research Collaboratory for Structural Bioinformatics (RCSB) 
protein database (http://www.rcsb.org/pdb/) for apo-CRABP-II, holo-CRABP-II, 
holo-CRABP-I, and Karyopherinα bound to the SV40 NLS peptide, 
respectively.  In the crystals, both CRABPs and karyopherinα are dimeric.  In 
all cases, the coordinates for the first monomer were used.  The available X-
ray crystal structure for apo-CRABP-II is of a mutant (R111A) (Chen et al., 
1998).  The mutation however is distant from the region studied and is 
believed to cause minimal perturbation of overall protein fold .   Molecular 
surfaces and electrostatic potentials were calculated using Swiss-PDB viewer 
ver. 3.6b3 (http://www.expasy.org/spdbv/) (Guex and Peitsch, 1997).  Swiss-
PDB viewer images were saved as pov3.1 files and rendered using POVRAY 
for windows, version 3.5 (http://www.povray.org/).  Sequence alignment was 
done using the Multalin multiple sequence alignment program 
(http://prodes.toulouse.inra.fr/multalin/multalin.html) (Corpet, 1988).  
 
   50
2.5.3 Vectors 
Mammalian expression vectors for hCRABP-II in pEGFP-C2, hCRABP-I 
in pSG5, hCRABP-II in pSG5, and bacterial expression vector for hCRABP-II 
in pET28a were previously described (Budhu et al., 2001; Budhu and Noy, 
2002).  Expression vector for importinα (hSRP1) was a gift from Karsten Weis 
(University of California, Berkeley). 
To generate NES-CRABP-II in pcDNA3.1, CRABP-II cDNA containing 
restriction sites for EcoRI (5’) and Xho1 (3’) was created by PCR amplification 
using hCRABP-II-pSG5 as a template.  Using EcoR1 and Xho1, K-FABP was 
cut from the K-FABP-NES-pcDNA3.1 vector (Tan et al., 2002) and replaced by 
the CRABP-II PCR product.  GFP-NES-CRABP was generated by cloning 
NES-CRABP-II cDNA into pEGFP-C2 (Clontech) using restriction sites for 
Kpn1 (5’) and BamH1 (3’).  GST-CRABP-II and GST-CRABP-I were generated 
by cloning the respective cDNAs into pGEX-4T2 (Amersham) using restriction 
sites for BamH1 (5’) and EcoR1 (3’).  CRABP-II-K20A/R29A/K30A was 
generated using the Stratagene quikchange site-directed mutagenesis kit.  
Template vectors were used to generate hCRABP-II-K20A, and the resultant 
vectors were used to create CRABP-II-K20A/R29A/K30A. 
 
2.5.4 Bacterially expressed proteins  
GST-tagged proteins were expressed in the E. coli strain BL21.  
Bacteria were grown in LB medium at 37°C to an O.D.600 nm of 0.7, and protein 
expression induced by 0.5 mM IPTG.  Following an additional 3 hr. at 30°C, 
bacteria were centrifuged and frozen at –20°C until use.  Pellets were 
homogenized in buffer A (500 mM NaCl, 20 mM TRIS, pH 7.4, 5 mM 
imidazole, 40 ml/1 l culture) containing lysozyme  and PMSF (200 μM).    51
Lysates were incubated with stirring (4°C, 20 min.), sonicated, centrifuged, 
and supernatants applied to a nickel-charged imidodiacetic acid agarose 
column (1 ml/1 l culture).  Column was rocked (3 hr., 4°C), washed with 3 
volumes buffer A containing 50 mM imidazole, and protein eluted with buffer A 
containing 500 mM  imidazole (10 ml/elution, 3 times).  Eluates were pooled, 
dialyzed against HEDK buffer (20 mM HEPES, pH 8.0, 1 mM EDTA, 1 mM 
DTT , 100 mM KCl), concentrated, diluted 1:2 with glycerol, and stored at –
20°C.  GST-tagged proteins were expressed and purified essentially the same 
way using HEDK buffer and glutathione-agarose.  Proteins were eluted (20 
mM tris, pH 8.0, 10 mM glutathione), dialyzed against HEDK, concentrated, 
diluted 1:2 with glycerol and stored at –20°C.  Protein concentrations were 
measured by the Bradford assay ((Bradford, 1976), BioRad), and viability 
assessed by monitoring RA-binding using fluorescence titrations.   
 
2.5.5 Urea-induced unfolding   
Proteins (1 μM) were incubated at varying urea concentrations (37ºC, 
15 min).  Emission spectra were recorded at 37ºC using a SPEX Industries 
Fluorolog 2 spectrofluorometer.   
 
2.5.6 Fluorescence titrations 
Protein (1 μM) was place in a cuvette and titrated with RA from a 
concentrated solution in ethanol.  Titrations were monitored by following the 
ligand-induced decrease in the intrinsic fluorescence of the protein (λex -280 
nm; λem -340 nm).  
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2.5.7 Coprecipitation assays  
35S-labeled importinα was generated by coupled in vitro 
transcription/translation (T7-TnT Coupled Reticulocyte Lysate System, 
Promega) following the manufacturer’s protocol..  Pull-down mixtures (1 ml in 
50 mM HEPES, pH 8.0, 100 mM NaCl, 0.05% NP40, 0.1% BSA) contained 
650 pmoles GST-tagged protein, 100 μl glutathione agarose (1/10 slurry), 50 
μl of TnT reaction, and RA (1.5 μM) or vehicle (ethanol).  Mixtures were 
incubated (4°C, 2 hr) and centrifuged.  Pelleted beads were washed (800 μl 
buffer containing RA or vehicle, 4 times), resuspended in 30 μl 2.5x SDS-
PAGE loading buffer, boiled, and resolved by 10% SDS-PAGE.  Gels were 
stained by Coomassie-blue, dried, and autoradiographed. 
 
2.5.8 Fluorescence microscopy  
To image endogenous CRABP-II, MCF-7 cells were seeded on multi-
well glass chamber slides and grown to 50-75% confluence in DMEM 
supplemented with 5% charcoal-treated FBS.  Medium was replaced by 
serum-free DMEM, and cells grown overnight followed by treatment with RA 
(100 nM, 30 min.) or vehicle.   
Cells were fixed using 3.7% formaldehyde in PBS (RT, 10 min.), 
permeabilized with Triton X-100 (0.2 % in PBS, 37°C, 10 min.), washed, and 
incubated with mouse monoclonal anti-CRABP-II antibodies (1:250 in PBS 
containing 2% BSA, 1hr.).  Cells were then incubated with the nucleic acid 
stain ToPro3 (Molecular Probes, 4 μl/ml in PBS, 15 min.), and with rabbit anti-
mouse Alexafluor-conjugated antibodies (Molecular Probes, 1:500 in PBS 
containing 2% BSA, 1 hr.), mounted with coverslips using slowfade light   53
reagent (Molecular Probes) and imaged using a Leica TCS SP2 confocal 
microscope system.   
To image GFP-tagged proteins, COS-7 cells were plated in 35 mm 
glass bottom microwell dishes (Mattek) in DMEM containing 5% charcoal-
treated FBS (75,000 cells per plate) and grown overnight.  Cells were 
transfected using Fugene (Roche) with an expression vector harboring the 
appropriate CRABP-II construct (250 ng DNA per plate) and pHcRed1-nuc 
(Clontech, 200 ng per plate).  Following an overnight incubation, medium was 
replaced with serum-free DMEM, and live cells were imaged using a Leica 
TCS SP2 confocal microscope equipped with a 40x dipping lens.  
Fluorescence of GFP and Red1-nuc were collected simultaneously. After 
imaging, cells were treated with 1 μM RA, incubated at 37°C for 30 min. and 
imaged again. 
 
2.5.9 Transactivation assays 
  COS-7 cells were seeded in 12 well plates (75,000 cells per well) in 
10% FBS in DMEM, grown overnight, and transfected with 500 ng RARE-luc 
reporter vector, 100 ng pCH110, and 500 ng of test plasmid.  Following an 
overnight incubation, medium was replaced with serum-free DMEM and cells 
treated with 250 nM RA or vehicle overnight.  Cell lysates were assayed for 
luciferase activity using the Luciferase Assay System (Promega).  Luciferase 
activity was corrected for transfection efficiency by the activity of β-
galactosidase. 
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